Formula milk companies are exploiting legal loopholes, say campaigners
BMJ 2022; 379 doi: https://doi.org/10.1136/bmj.o2926 (Published 07 December 2022) Cite this as: BMJ 2022;379:o2926- Jacqui Wise
- Kent
Formula companies are exploiting legal loopholes by selling infant milks that should be available only on prescription and used under medical supervision, infant feeding campaigners have said.
The practice risks damaging infants’ health by increasing the risk of life threatening infections, dental caries, and obesity and leaving parents and carers out of pocket because of high prices.
Babies who are not exclusively breastfed and who have diagnoses of clinical conditions such as an allergy or a metabolic disorder may need a specialised infant milk. These products fall under regulations that govern foods for special medical purposes (FSMP), which are stricter than those for other infant formula or follow-on formula products. However, commercial milk formula manufacturers themselves decide which infant milks are marketed as infant foods for special medical purposes (iFSMP), with little legal oversight, a report from the Baby Feeding Law Group has said.1
This means that some milks, including lactose-free and anti-reflux formulas, are freely available from retailers without medical supervision. Parents may be encouraged to treat their baby with such products rather than seeking medical advice. It also means that those parents of babies with a true clinical need for a product may be being told to buy the products rather than get them on prescription.
“The …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.